The standard treatment for HoFH is LDL apheresis combined with maximum tolerated potent statins, ezetimibe and bile acid sequestrants. In untreated HoFH, coronary heart disease usually develops in ...

Guidelines for the use of Lp apheresis to treat FH homozygotes and heterozygotes with coronary heart disease (CHD) and raised LDL levels despite optimal drug therapy have been published in several ...

Apheresis machine for extracorporeal elimination of LDL cholesterol in patients with familial hypercholesterolemia, hyperlipoproteinemia (a), hyperfibrinogenemia, transplant vasculopathy.

Overall, the use of mipomersen and lomitapide in clinical practice is limited, and these agents are generally prescribed as an add-on to statin treatment in HoFH patients who cannot undergo LDL ...

The global Apheresis Equipment Market is valued at $2.01 million in 2023 and is projected to reach a value of $2.20 million by 2032, growing at a Compound Annual Growth Rate (CAGR) of 3.7% from 2024 ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

which can improve other risk factors like LDL-cholesterol. Lipoprotein apheresis is, meanwhile ,a very efficient but also time-consuming and expensive therapy, meaning it tends to be used only in ...

Feb. 3, 2025 — Low-density lipoproteins (LDL) -- commonly known as bad cholesterol -- have long been on scientists' radar as a major contributor to heart disease. But these microscopic ...

Amicus™ high collection efficiency yields multiple products per donor for the lowest-cost platelet production. It is designed to adapt to the requirements of different collection settings. Let ...

The Co-Operative Center for Excellence in Hematology Cell Procurement & Processing Lab currently has an active protocol which allows one to participate as a Donor of Peripheral Blood Mononuclear Cells ...